1.湖南中医药大学,湖南省长沙市岳麓区学士路300号,410208
2.湖南中医药大学第一附属医院
通信作者:154451101@qq. com
收稿:2025-06-27,
修回:2025-11-14,
纸质出版:2026-01-17
移动端阅览
刘溪源,李江伟,寻馨等.彭清华从肺论治玻璃体混浊经验[J].中医杂志,2026,67(02):131-135.
LIU Xiyuan,LI Jiangwei,XUN Xin,et al.PENG Qinghua's Experience in Treating Vitreous Opacity from the Perspective of Lungs[J].Journal of Traditional Chinese Medicine,2026,67(02):131-135.
刘溪源,李江伟,寻馨等.彭清华从肺论治玻璃体混浊经验[J].中医杂志,2026,67(02):131-135. DOI: 10.13288/j.11-2166/r.2026.02.003.
LIU Xiyuan,LI Jiangwei,XUN Xin,et al.PENG Qinghua's Experience in Treating Vitreous Opacity from the Perspective of Lungs[J].Journal of Traditional Chinese Medicine,2026,67(02):131-135. DOI: 10.13288/j.11-2166/r.2026.02.003.
总结彭清华教授从肺论治玻璃体混浊的临床经验。通过分析肺与神膏在生理特性、病机演变上的关联性,提出肺失治节为玻璃体混浊的核心病机,并贯穿气虚浊凝、湿瘀互结、金不生水、金不制木四个病理环节。针对肺气失宣、神膏失养,治以补益肺气、通调水道,方用补肺汤合五苓散加减;肺失通调、湿瘀上泛,治以活血利水、化瘀散结,方用生蒲黄汤合猪苓散加减;金不生水、精亏失荣,治以益气养阴、肺肾同补,方用补肺汤合生脉散加减;金不制木、气血逆乱,治以金木制化、疏肝理肺,常用四逆散合贝母瓜蒌散加减。
To summarize Professor PENG Qinghua's clinical experience in treating vitreous opacity from the perspective of lungs. By analyzing the correlation between lungs and vitreous body in physiological characteristics and pathogenesis evolution, it is proposed that "lungs failure to manage and regulate" is the core pathogenesis of vitreous opacity, which runs through four pathological stages i.e.
qi
deficiency leading to turbidity coagulation, dampness blinding with stasis, metal failure to generate water, and metal failure to control wood. For lung
qi
failure to diffuse and vitreous humor failure to nourish, the treatment should tonify lung
qi
, regulate the waterways, prescribing modified
Bufei Decoction
(补肺汤) plus
Wuling Powder
(五苓散); for lungs failure to free and regulate, with upward diffusion of dampness and stasis, the treatment should promote blood circulation and drain wat
er, resolve stasis and dissipate masses, prescribing modified
Shengpuhuang Decoction
(生蒲黄汤) combined with
Zhuling Powder
(猪苓散); for metal failure to generate water accompanied by essence deficiency and malnutrition, the treatment should tonify
qi
and nourish
yin
as well as replenish both lungs and kidneys, with modified
Bufei Decoction
(补肺汤) combined with
Shengmai Powder
(生脉散); for metal failure to control wood resulting in disorder of
qi
and blood, the treatment should focus on regulating the mutual restriction between metal and wood, soothing the liver and regulating the lungs, usually with modified
Sini Powder
(四逆散) combined with
Beimu Guolou Powder
(贝母瓜蒌散).
彭清华 . 中医眼科学 [M]. 北京 : 中国中医药出版社 , 2021 : 160 - 162 .
畅立斌 , 袁梦克 , 许正杰 , 等 . 玻璃体混浊患者的焦虑障碍筛查研究 [J]. 北京医学 , 2021 , 43 ( 3 ): 265 - 267 .
朱雯雪 , 蔡岩 . 飞蚊症的病因研究及治疗新进展 [J]. 国际眼科杂志 , 2025 , 25 ( 3 ): 446 - 450 .
丁宁 , 高卫萍 . 玻璃体混浊的中医古籍文献研究 [J]. 中国中医眼科杂志 , 2023 , 33 ( 2 ): 155 - 159 .
罗国芬 . 陈达夫中医眼科临床经验 [M]. 北京 : 中国中医药出版社 , 2016 : 29 - 55,184 .
廖梦宇 , 宋尹婷 , 颜华 . 增生型糖尿病视网膜病变玻璃体中微粒水平及其临床意义 [J]. 中华眼底病杂志 , 2021 , 37 ( 8 ): 610 - 616 .
MONTERO JA , RUIZ-MORENO JM , CORREA ME . Intravitreal anti-VEGF drugs as adjuvant therapy in diabetic retinopathy surgery [J]. Curr Diabetes Rev , 2011 , 7 ( 3 ): 176 - 184 .
董建国 . 补肺汤加减治疗玻璃体混浊临床分析 [J]. 中国社区医师(综合版) , 2007 , 9 ( 16 ): 93 .
王灿宇 , 杨锐煜 , 邵毅 , 等 . 氧化应激在眼部疾病中的作用机制及治疗策略研究 [J]. 眼科新进展 , 2025 , 45 ( 3 ): 247 - 252 .
宋海姣 , 金明 . 眼底黄斑水肿之三阴辨治思考 [J]. 中国医药导报 , 2022 , 19 ( 3 ): 119 - 122 .
EYSTEINSSON T , HARDARSON SH , BRAGASON D , et al . Retinal vessel oxygen saturation and vessel diameter in retinitis pigmentosa [J]. Acta Ophthalmol , 2014 , 92 ( 5 ): 449 - 453 .
0
浏览量
1
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010102007558号